Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Exceptional extension!
Enjoy this offer
* See conditions under "Our services"

Valuation: Abbott Laboratories

Market Cap 153B 134B 124B 116B 217B 14,492B 221B 1,487B 576B 7,110B 574B 562B 24,713B P/E 2026 *
22.1x
P/E 2027 * 18.9x
Enterprise Value 165B 145B 133B 125B 234B 15,603B 238B 1,601B 620B 7,656B 618B 605B 26,608B EV / Sales 2026 *
3.28x
EV / Sales 2027 * 2.95x
Free-Float
86.73%
Yield 2026 *
2.9%
Yield 2027 * 3.09%
1 day+3.17%
1 week-0.26%
Current month+5.58%
1 month+4.28%
3 months-13.80%
6 months-27.43%
Current year-27.86%
1 week 87.21
Extreme 87.21
91.58
1 month 84.96
Extreme 84.96
92.73
Current year 81.97
Extreme 81.97
129.46
1 year 81.97
Extreme 81.97
139.06
3 years 81.97
Extreme 81.97
141.23
5 years 81.97
Extreme 81.97
142.6
10 years 36.76
Extreme 36.76
142.6
Manager TitleAgeSince
Chief Executive Officer 52 2020-03-30
Director of Finance/CFO 53 2023-08-31
Chief Investment Officer 51 -
Director TitleAgeSince
Director/Board Member 64 2011-12-08
Director/Board Member 67 2011-12-08
Director/Board Member 71 2017-02-15
Date Insider Type Main position Quantity % Market Cap.
Apr. 27Other

Head of Human Resources

5,314 0.0003%
Apr. 23Free

Director

2,286 0.0001%
Apr. 23Free

Director

2,286 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
+3.16%-0.26%-32.18%-16.35% 153B
+1.34%-1.33%-6.66%-8.28% 101B
-1.82%-0.54%+56.86%+55.61% 55.9B
+4.12%+0.46%-3.54%+50.66% 52.78B
+3.04%-0.29%-14.65%-43.54% 38.77B
+1.31%-4.85% - - 29.35B
+0.56%-4.93%-12.89%-45.13% 26.65B
+1.50%+1.50%+54.38%-8.84% 23.29B
-2.25%-1.92%-16.37%-5.76% 20.51B
+0.84%-2.24%-14.78%-4.23% 19.53B
Average +1.18%-2.40%+1.13%-2.87% 52.12B
Weighted average by Cap. +1.75%-1.81%-5.85%-1.74%

Financials

2026 *2027 *
Net sales 50.29B 44.18B 40.71B 38.11B 71.4B 4,764B 72.6B 489B 189B 2,337B 189B 185B 8,124B 54.79B 48.14B 44.35B 41.52B 77.79B 5,190B 79.1B 533B 206B 2,547B 206B 201B 8,851B
Net income 7.02B 6.17B 5.68B 5.32B 9.97B 665B 10.13B 68.22B 26.41B 326B 26.35B 25.78B 1,134B 8.39B 7.37B 6.79B 6.36B 11.92B 795B 12.12B 81.57B 31.58B 390B 31.5B 30.83B 1,356B
Net Debt 11.73B 10.3B 9.49B 8.89B 16.65B 1,111B 16.93B 114B 44.12B 545B 44.02B 43.07B 1,894B 8.88B 7.8B 7.19B 6.73B 12.61B 841B 12.82B 86.34B 33.42B 413B 33.35B 32.63B 1,435B
Logo Abbott Laboratories
Abbott Laboratories specializes in the research, development, manufacturing and marketing of pharmaceutical and medical products. Net sales break down by family of products as follows: - vascular devices (48.3%): endoprosthetic systems, dilation catheters, arterial closures, etc.; - diagnostic systems and instruments (20.2%); - nutrition products (19.1%): pediatric nutrition products, nutritional supplements, and dietetic products; - medicine (12.4%): anesthetics, antiviral products, antibiotics, inhibitors, anti-inflammatories, etc. Net sales are distributed geographically as follows: the United States (38.7%), Germany (6.2%), China (4.3%), India (4.2%), Switzerland (4.2%), Japan (3.3%), the United Kingdom (3%) and others (36.1%).
Employees
115,000
Date Price Change Volume
26-06-23 $90.67 +3.23% 6,389,062
26-06-22 $87.83 -0.66% 11,458,235
26-06-18 $88.41 -0.10% 41,964,841
26-06-17 $88.50 -2.34% 13,052,998
26-06-16 $90.62 +2.20% 12,740,746
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
27
Last Close Price
87.83USD
Average target price
116.54USD
Spread / Average Target
+32.69%

Quarterly revenue - Rate of surprise

-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!